Danaher (NYSE:DHR) Price Target Lowered to $220.00 at Bank of America

Key Points

• Bank of America has reduced its price target for Danaher from $230.00 to $220.00, indicating a potential upside of 15.23% based on the stock's previous close.
• Danaher recently reported earnings of $1.80 per share, surpassing expectations and showing a revenue growth of 3.4% year-over-year.
• A majority of analysts maintain a positive outlook on the stock, with a consensus rating of "Moderate Buy" and an average price target of $245.91.

Danaher (NYSE:DHR - Get Free Report) had its target price reduced by research analysts at Bank of America from $230.00 to $220.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has a "buy" rating on the conglomerate's stock. Bank of America's target price would indicate a potential upside of 16.30% from the company's previous close.

Other research analysts also recently issued research reports about the stock. Evercore ISI cut their price target on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a report on Tuesday, July 8th. Guggenheim restated a "buy" rating and set a $250.00 price target on shares of Danaher in a report on Wednesday, July 23rd. Wall Street Zen upgraded shares of Danaher from a "hold" rating to a "buy" rating in a report on Friday, June 27th. UBS Group cut their price target on shares of Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a report on Wednesday, July 23rd. Finally, Barclays restated an "overweight" rating and set a $225.00 price target (up previously from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Seventeen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $245.91.

Danaher Stock Down 0.7%

DHR stock traded down $1.30 during midday trading on Monday, reaching $189.16. The company had a trading volume of 313,867 shares, compared to its average volume of 4,122,841. Danaher has a 1 year low of $171.00 and a 1 year high of $279.90. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $135.45 billion, a P/E ratio of 40.25, a PEG ratio of 2.70 and a beta of 0.75. The company has a 50 day moving average of $200.02 and a two-hundred day moving average of $198.03.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter in the prior year, the firm earned $1.72 EPS. The company's revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities research analysts expect that Danaher will post 7.63 earnings per share for the current fiscal year.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the firm's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 11.20% of the stock is owned by corporate insiders.

Institutional Trading of Danaher

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. White Pine Capital LLC grew its position in Danaher by 1.4% in the 2nd quarter. White Pine Capital LLC now owns 3,494 shares of the conglomerate's stock worth $690,000 after purchasing an additional 49 shares during the last quarter. Boyd Watterson Asset Management LLC OH grew its position in Danaher by 2.1% in the 2nd quarter. Boyd Watterson Asset Management LLC OH now owns 2,524 shares of the conglomerate's stock worth $499,000 after purchasing an additional 51 shares during the last quarter. Hills Bank & Trust Co grew its position in Danaher by 0.3% in the 1st quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate's stock worth $3,693,000 after purchasing an additional 53 shares during the last quarter. Worth Financial Advisory Group LLC grew its position in Danaher by 4.6% in the 2nd quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate's stock worth $236,000 after purchasing an additional 53 shares during the last quarter. Finally, Sageworth Trust Co boosted its position in shares of Danaher by 2.3% during the 1st quarter. Sageworth Trust Co now owns 2,404 shares of the conglomerate's stock valued at $493,000 after acquiring an additional 54 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.